Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials

BACKGROUND: Migraine clinical profile may change with age, making it necessary to verify that migraine treatments are equally safe and effective in older patients. These analyses evaluated the effects of patient age on the pharmacokinetics (PK), efficacy, and safety of galcanezumab for prevention of...

Descripción completa

Detalles Bibliográficos
Autores principales: Stauffer, Virginia L., Turner, Ira, Kemmer, Phebe, Kielbasa, William, Day, Kathleen, Port, Martha, Quinlan, Tonya, Camporeale, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310276/
https://www.ncbi.nlm.nih.gov/pubmed/32576229
http://dx.doi.org/10.1186/s10194-020-01148-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310276/
https://www.ncbi.nlm.nih.gov/pubmed/32576229
http://dx.doi.org/10.1186/s10194-020-01148-9

Ejemplares similares